Search results
Discover how Medable helped digitize and standardize a client's participant pain body maps for a diabetic polyneuropathy trial.
Medable’s Privacy Statement applies to your use of the Medable.com websites (the “Sites”) as well as certain Medable Services (the “Services”).
This DBM App is the app and analytics platform for healthcare. Review the Medable DBM app Privacy Statement here.
On December 23, 2023, the FDA released guidance for the industry on how digital health technologies (DHTs) should be used in clinical trials. Below is a summary of each section contained above, to read through the FDA’s full text, click here.
Medable’s Privacy Statement applies to your use of the Medable.com websites (the “Sites”) as well as certain Medable Services (the “Services”).
Medable’s Privacy Statement applies to your use of the Medable.com websites (the “Sites”) as well as certain Medable Services (the “Services”).
Medable’s Privacy Statement applies to your use of the Medable.com websites (the “Sites”) as well as certain Medable Services (the “Services”).
Medable’s Privacy Statement applies to your use of the Medable.com websites (the “Sites”) as well as certain Medable Services (the “Services”).
Accelerate therapeutic discovery and maximize ROI with our streamlined platform, fully integrated across your entire portfolio. Use digital and decentralized trials to scale your pipeline beyond what's possible with traditional clinical trials.
Medable's Access app was created during the epidemiological emergency created by the SARS-CoV-2 virus. Review the app privacy statement here.
Explore the prevalent challenges encountered in eCOA clinical trials, from technical issues and patient adherence to data security and regulatory adherence, and discover strategies for mitigation.
Join leading clinical experts as they discuss and debunk the top 5 myths about eCOA in 2025, separating fact from fiction to help clinical operations, procurement, and data management teams make smarter, faster decisions.
In January 2024, panelists from Syneos, Obvious Ventures, Sapphire Ventures, IDEA Pharma, and GSR Ventures joined Medable’s CEO, Dr. Michelle Longmire, to discuss the purpose, potential, and power that artificial intelligence (AI) technology offers clinical trials. Here's what they had to say.
Within clinical research, email is not just a compliant and valuable tool, it’s commonly the gold standard when communicating with participants. Read on to find out why.
The TOGETHERCare App was created to help caregivers implement home-based care for cancer survivors. Review the Medable TOGETHERCare app Privacy Statement here.
Navigating the complexities of eCOA vendor selection can be tough. This comprehensive guide provides a step-by-step approach, covering everything from vendor evaluation to successful implementation, ensuring your clinical trial's success.
Medable’s AI capabilities are advanced tools designed to enhance clinical trial processes by automating and optimizing the eCOA build experience. These capabilities leverage cutting-edge AI technology to automatically generate the digital version of an eCOA from the paper version (PDF). Medable’s AI empowers users to accomplish repetitive build activities, such as repeated scales for long questionnaires, using simple prompts in our intelligent chat interface.
This blog describes software as a service and how the life sciences industry uses it today.
Explore practical strategies for ensuring data quality in eCOA clinical trials, covering platform design, patient engagement, data validation, and regulatory adherence.
With the 14th annual DPHARM® wrapping up, we talked to our peers across the industry to find out what the big themes and takeaways were from this year’s conference.
Electronic patient-reported outcomes and electronic clinical outcome assessments capture real-time, quality data for clinical trials. Learn how at Medable.
Gain a quick overview of what top trends and topics dominated DIA 2023.
Consult directly with an award-winning Medable SME about your trial and discover how to enable faster, easier, clinical trials through patient-focused experiences. Chat about best practices in protocol design and digital standardization, learn how the latest FDA & EU guidelines will impact you, or see client use cases on cost and time savings.
Learn how we can help you navigate the complexities of clinical operations so that you can meet your study's milestones faster and easier.
Medable’s Privacy Statement applies to your use of the Medable.com websites (the “Sites”) as well as certain Medable Services (the “Services”).
See how customers have had success with Medable, our trial platform, and our teams.
Streamline your clinical trial and generate high-quality data with a #1 rated, easy-to-use platform, offered in over 60 countries and 120 languages. Book a demo to learn more.
Learn the basics of digital medicine and how it's evolving with this blog.
The partnership between Medable, U.S. Renal Care, and the top ten pharmaceutical sponsor exemplifies the transformative power of Medable’s Total Consent solution in clinical trials. By overcoming common misconceptions around participant age, cost, and complexity, Medable’s platform proved to be a flexible, fast, and efficient solution for the elderly renal care population. U.S. Renal Care sought to use Medable’s Total Consent (Medable’s eConsent solution) for an investigator-initiated trial. The phase 4 trial, which was funded by a top 10 pharmaceutical company, sought to enroll elderly participants suffering from Anemia ESKD (End Stage Kidney Disease) across 476 site users. The trial would be managed by three central principal investigators (PIs).
This Televisit App facilitates visits between a healthcare provider & patient in a HIPPA-secure manner. Review the Medable Televisit app Privacy Statement here.
Discover a unified digital platform for clinical trials with best-in-class decentralized and eCOA software. Streamline data collection, scale globally, and deliver smarter, faster results.
Medable’s Privacy Statement applies to your use of the Medable.com websites (the “Sites”) as well as certain Medable Services (the “Services”).
Learn what impacts the new European Medicine Regulatory Network recommendations paper means to your clinical trial operations.
This Privacy Center is intended to help you identify the Medable privacy practices & Privacy Statements which apply to your use of Medable websites/applications.
See how a pharmaceutical company used data gathered during the informed consent process to pre-populate their site's systems, as well as their own.
We aimed to develop a mobile app incorporating user preferences to enable cancer survivors' care partners to monitor the survivors' health and to provide care partner resources.
Designed to meet specific therapeutic area needs, whether you need quick deployment or long-term follow-up. Medable’s therapeutic area solutions enable better user experience, high-quality data, and proven ROI to your portfolio. Click to learn more.
Discover how eCOA software enhances clinical trials with real-time data capture, faster, scalable builds, and a modern, consumer-grade experience. Learn why cloud-based solutions improve efficiency, compliance, and patient engagement.
Medable delivers eConsent and a two-week study startup for a client’s first-ever digital trials